publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
high
serum
procalcitonin
concentr
patient
sepsi
infect
high
concentr
calcitoninlik
immunoreact
found
blood
patient
variou
extrathyroid
diseas
mean
monoclon
immunoradiometr
assay
calcitonin
precursor
measur
serum
concentr
procalcitonin
patient
variou
bacteri
viral
infect
children
newborn
age
year
hospit
suspect
infect
investig
prospect
patient
sever
bacteri
infect
high
serum
concentr
procalcitonin
diagnosi
rang
ngml
comparison
children
found
sign
infect
baselin
concentr
middot
ngml
serum
procalcitonin
valu
decreas
rapidli
antibiot
therapi
patient
peripher
bacteri
colonis
local
infect
without
invas
sepsi
patient
viral
infect
concentr
within
slightli
normal
rang
middot
ngml
among
sever
burn
patient
studi
intens
care
unit
posttraumat
cours
procalcitonin
concentr
rang
middot
ngml
close
relat
infecti
complic
acut
septic
episod
concentr
matur
calcitonin
normal
subject
whatev
procalcitonin
concentr
found
concentr
substanc
immunolog
ident
procalcitonin
rais
septic
condit
serum
concentr
seem
correl
sever
microbi
invas
increas
product
calcitonin
medullari
thyroid
carcinoma
mtc
well
known
serum
calcitonin
use
marker
cancer
high
serum
concentr
calcitoninlik
immunoreact
also
report
variou
extrathyroid
disord
includ
mani
cancer
acut
chronic
inflammatori
diseas
lung
acut
pancreat
renal
failur
benign
liver
diseas
fulmin
infantil
meningococcaemia
presenc
sever
circul
immunoreact
form
calcitonin
precursor
mtc
patient
shown
sever
group
natur
circul
immunoreact
calcitonin
speci
disord
remain
unknown
howev
ghillani
late
show
unlik
mtc
produc
precursor
matur
hormon
extrathyroid
diseas
produc
calcitonin
precursor
absenc
matur
hormon
investig
calcitonin
speci
patient
sever
bacteri
infect
sepsi
two
group
patient
studi
first
compris
newborn
older
infant
children
admit
paediatr
unit
suspect
infect
tabl
second
includ
sever
burn
patient
admit
intens
care
unit
burn
injuri
bodi
surfac
area
blood
sampl
centrifug
min
g
serum
store
deg
c
analysi
procalcitonin
measur
monoclon
immunoradiometr
assay
mirma
assay
use
two
monoclon
antibodi
one
direct
residu
procalcitonin
captur
antibodi
one
recognis
residu
tracer
antibodi
fig
assay
detect
limit
pgml
serum
calcitonin
measur
commerci
mirma
ci
biointern
gif
sur
yvett
franc
specif
matur
calcitonin
sensit
limit
pgml
circul
immunoreact
form
calcitonin
analys
reversephas
highperform
liquid
chromatographi
hplc
partial
purif
seppak
cartridg
serum
inject
c
machereynagel
diiren
germani
column
equilibr
volum
trifluoroacet
acid
column
elut
room
temperatur
flow
rate
ml
per
min
min
gradient
acetonitril
trifluoracet
acid
immunoreact
fraction
test
four
assay
two
describ
radioimmunoassay
base
polyclon
goat
antiserum
direct
residu
procalcitonin
recognis
procalcitonin
put
cleavag
peptid
irma
use
polyclon
antiserum
procalcitonin
monoclon
antibodi
direct
residu
detect
entir
procalcitonin
fig
fig
show
distribut
procalcitonin
concentr
five
subgroup
children
without
infect
procalcitonin
undetect
ngml
children
without
infect
time
diagnosi
newborn
infant
older
infant
children
sever
bacteri
infect
high
serum
concentr
procalcitonin
ngml
antibiot
treatment
rapidli
decreas
procalcitonin
concentr
day
treatment
among
infant
children
locoregion
infect
newborn
infant
skin
bacteri
colonis
sepsi
procalcitonin
concentr
exceed
ngml
ngml
patient
viral
infect
valu
within
slightli
normal
rang
maximum
ngml
children
gastroenter
coronaviru
rotaviru
valu
ngml
ngml
child
acut
hepat
concentr
ngml
admiss
ngml
day
serum
procalcitonin
concentr
vari
wide
among
burn
patient
ngml
three
procalcitonin
concentr
ngml
ngml
within
day
burn
concentr
fell
progress
normal
subgroup
patient
infecti
complic
hospit
stay
patient
subgroup
ii
higher
valu
ngml
peak
concentr
found
onset
sepsi
confirm
clinic
microbiolog
sign
subgroup
iii
serum
concentr
patient
high
day
burn
ngml
ngml
ngml
continu
rise
next
day
acut
septic
episod
patient
sever
infecti
complic
e
coli
posit
blood
cultur
day
septic
shock
day
pseudomona
aerwinosa
posit
cultur
day
high
concentr
procalcitonin
serum
sampl
highest
valu
ngml
measur
septic
shock
patient
subgroup
iii
toxic
shock
syndrom
day
bum
procalcitonin
reach
maximum
ngml
time
burn
patient
subgroup
ii
die
pulmonari
embol
day
injuri
concentr
matur
calcitonin
normal
time
burn
patient
children
analysi
serum
extract
reversephas
hplc
show
major
peak
elut
min
detect
sever
immunoassay
fig
like
immunoreact
peak
correspond
whole
molecul
procalcitonin
two
small
peak
detect
sampl
could
identifi
calcitonin
consist
undetect
specif
mirma
serum
calcitoninlik
immunoreact
report
variou
extrathyroid
studi
show
serum
concentr
substanc
immunolog
ident
procalcitonin
increas
onset
infect
addit
serum
concentr
substanc
seem
correl
sever
infect
children
procalcitonin
concentr
ngml
diagnosi
sever
bacteri
sepsi
confirm
microbiolog
studi
bum
patient
suggest
bum
injuri
may
lead
moder
system
releas
procalcitonin
howev
among
patient
high
peak
concentr
procalcitonin
associ
septic
complic
although
direct
correl
found
postbum
cours
procalcitonin
concentr
size
bum
pulmonari
injuri
correl
procalcitonin
sever
infect
confirm
find
serum
concentr
ngml
time
normal
valu
patient
septic
shock
data
shown
antibiot
treatment
lower
procalcitonin
rapidli
contrast
high
circul
procalcitonin
concentr
persist
burn
patient
overwhelm
microbi
invas
long
septic
episod
procalcitonin
molecul
origin
thyroid
gland
tissu
patient
thyroid
ccell
seem
product
site
procalcitonin
inde
burn
patient
undergon
thyroidectomi
year
earlier
high
procalcitonin
valu
secret
matur
calcitonin
find
procalcitonin
detect
absenc
matur
calcitonin
show
procalcitoninproduc
cell
unabl
process
precursor
form
matur
hormon
mtc
capabl
produc
secret
biosynthet
pathway
pulmonari
neuroendocrin
cell
bronchial
epithelium
report
major
sourc
calcitonin
immunoreact
howev
patient
sepsi
pulmonari
injuri
other
report
isol
presenc
calcitonin
precursor
patient
benign
liver
diseas
hepat
hepatocellular
carcinoma
also
presenc
calcitoninrel
rna
perhap
liver
site
procalcitonin
product
patient
sepsi
sinc
serum
calcitoninlik
immunoreact
describ
wide
varieti
extrathyroid
diseas
like
inflammatori
process
infect
lead
elabor
calcitoninlik
immunoreact
variou
type
cell
immunoreact
clinic
pictur
resembl
sepsi
report
patient
acut
pancreatitiss
place
procalcitonin
induct
cytokin
cascad
occur
sepsi
inflammatori
process
remain
investig
rapid
substanti
releas
procalcitonin
time
tumour
necrosi
factor
alpha
observ
patient
renal
cancer
intraven
administr
unpublish
observ
could
help
elucid
mechan
rapid
procalcitonin
product
septic
process
result
base
sever
specif
immunoassay
strongli
suggest
molecul
detect
serum
patient
sepsi
procalcitonin
howev
exclud
possibl
aminoacid
involv
recognis
epitop
may
differ
second
calcitonin
messeng
encod
procalcitonin
bear
eight
differ
aminoacid
residu
carboxytermin
region
identifi
thyroid
concentr
calcitonin
generel
peptid
product
calcitonin
gene
nerv
cell
also
increas
patient
studi
need
elucid
import
procalcitonin
product
associ
infect
assess
potenti
role
diagnosi
followup
patient
bacteri
sepsi
thank
mr
johni
bombl
mr
lionel
fougeat
excel
assist
dr
walter
bom
research
laboratori
calcium
metabol
univers
zurich
progr
peptid
polyclon
antiserum
dr
jeanmichel
bidart
review
manuscript
